Trials / Unknown
UnknownNCT02313792
Palifermin for Patients Receiving Hematopoietic Stem Cell Transplantation
Efficacy, Safety and Quality of Life of Palifermin on Reducing Oral Mucositis in Patients With Hematopoietic Stem Cell Transplantation, Prospective Double-blind Randomized Phase III Trial
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 88 (estimated)
- Sponsor
- The Catholic University of Korea · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy and safety of palifermin on reducing mucositis for patients receiving autologous or allogeneic stem cell transplantation with supportive care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Palifermin |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-03-01
- Completion
- 2015-06-01
- First posted
- 2014-12-10
- Last updated
- 2014-12-10
Source: ClinicalTrials.gov record NCT02313792. Inclusion in this directory is not an endorsement.